Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Print view.
German.
Contact.
Data entry.
Start.
Open Access.

Navigation/Search

Researchers.
Institutions.
Projects.
Publications.
Partners.
Sponsors.
Equipment.
Knowhow.
Fields of Research.

Selected Publication:

Binder, F.
SGLT2 Inhibitors in Heart Failure: A Systematic Review of Therapeutic Effects Across Ejection Fraction and Diabetic Status
Humanmedizin; [ Diplomarbeit ] Medizinische Universität Graz; 2025. pp. 57 [OPEN ACCESS]
FullText

Authors Med Uni Graz:
Advisor:: ATALLAH Reham; Heinemann Akos
Altmetrics:
Abstract:: Sodium-glucose cotransporter 2 (SGLT2) inhibitors have emerged as a novel therapeutic option in heart failure (HF), originally introduced for the management of type 2 diabetes. Recent evidence has highlighted their cardiovascular and renal benefits in both diabetic and non-diabetic patients with HF. However, their efficacy across the full spectrum of HF phenotypes, particularly in regard to key clinical outcomes, remains an area of active investigation.